Creatine
Creatine, licence 80047283: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Maximum Human Performance
- NPN or DIN-HM
- 80047283
- Status
- Active licence
- Licence date
- 17 December 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-(Aminoiminométhyl)-N-méthylglycine monohydraté Source : Créatine monohydratée | 5.0 g | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adults (Maintenance Phase) | Not specified | 1.0 Cuillère à thé | 1.0 Jour(s) |
| Adults (Loading Phase) | Not specified | 1.0 Cuillère à thé | 4.0 Jour(s) |
Uses authorised in Canada
Creatine monohydrate increases muscle size when used in conjunction with a resistance training regimen. Creatine monohydrate improves strength in repetitive bouts of brief, highly intense physical activity by increasing muscle energy levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have a kidney disorder. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. May result in weight gain.
Source
Official Health Canada record, licence 80047283
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.